Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002896255 | SCV003642351 | uncertain significance | Inborn genetic diseases | 2022-08-11 | criteria provided, single submitter | clinical testing | The c.13609A>G (p.S4537G) alteration is located in exon 52 (coding exon 52) of the KMT2C gene. This alteration results from a A to G substitution at nucleotide position 13609, causing the serine (S) at amino acid position 4537 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |